Comments
Loading...
Bonus BioGroup Analyst Ratings and Price Targets | OTC:BBIXF | Benzinga
Bonus BioGroup Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Bonus BioGroup Corp from these most-recent analyst ratings.
Analyst Ratings for Bonus BioGroup
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Bonus BioGroup (BBIXF) stock?
There is no price target for Bonus BioGroup
What is the most recent analyst rating for Bonus BioGroup (BBIXF)?
There is no analyst for Bonus BioGroup
When was the last upgrade for Bonus BioGroup (BBIXF)?
There is no last upgrade for Bonus BioGroup
When was the last downgrade for Bonus BioGroup (BBIXF)?
There is no last downgrade for Bonus BioGroup.
When is the next analyst rating going to be posted or updated for Bonus BioGroup (BBIXF)?
There is no next analyst rating for Bonus BioGroup.
Is the Analyst Rating Bonus BioGroup (BBIXF) correct?
There is no next analyst rating for Bonus BioGroup.
Browse analyst ratings and price targets on all stocks.
